Deep Versus Moderate Neuromuscular Blockade in Bariatric Surgery
ConditionNeuromuscular Blockade
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity Hospital of Patras
About this trial
The aim of this study is to investigate the effect of depth of neuromuscular blockade on the surgical field, patient postoperative pain, intestinal motility, the incidence of postoperative nausea and vomiting and the effect of deep versus moderate neuromuscular blockade on postoperative atelectasis quantitatively using chest computed tomography.This is a prospective, randomized, controlled clinical-controlled study in patients ≥18 years old scheduled to undergo elective bariatric surgery.
Eligibility criteria
Qualifiers
Patients aged ≥18 years ASA II-III who are to undergo planned laparoscopic bariatric surgery
Disqualifiers
ASA 4 patients
Maternal population
Patients who are not scheduled to receive general anesthesia, but some other type of anesthesia.
Contraindicated patients: administration of neuromuscular blockade, suppression of spontaneous respiration, and those with an indication for awake intubation or surgical airway.
Trial design
Treatments tested in this trial
- Deep neuromascular blockage
- Moderate neuromascular blockage
Treatment groups
50 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov